Cozzi PJ - Search Results

1

Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.

Li Y, Abbas Rizvi SM, Blair nee Brown JM, Cozzi PJ, Qu CF, Ow KT, Tam PN, Perkins AC, Russell PJ, Allen BJ. Li Y, et al. Among authors: cozzi pj. Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):896-908. doi: 10.1016/j.ijrobp.2004.04.035. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465208

2

Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.

Russell PJ, Ow KT, Tam PN, Juarez J, Kingsley EA, Qu CF, Li Y, Cozzi PJ, Martiniello-Wilks R. Russell PJ, et al. Among authors: cozzi pj. Cancer Immunol Immunother. 2004 Nov;53(11):995-1004. doi: 10.1007/s00262-004-0527-7. Epub 2004 Jul 28. Cancer Immunol Immunother. 2004. PMID: 15449043 Free PMC article.

3

Targeting uPA/uPAR in prostate cancer.

Li Y, Cozzi PJ. Li Y, et al. Among authors: cozzi pj. Cancer Treat Rev. 2007 Oct;33(6):521-7. doi: 10.1016/j.ctrv.2007.06.003. Epub 2007 Jul 19. Cancer Treat Rev. 2007. PMID: 17658220 Review.

4

Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.

Li Y, Cozzi PJ, Qu CF, Zhang DY, Abbas Rizvi SM, Raja C, Allen BJ. Li Y, et al. Among authors: cozzi pj. Cancer Lett. 2004 Mar 18;205(2):161-71. doi: 10.1016/j.canlet.2003.10.035. Cancer Lett. 2004. PMID: 15036648

5

Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.

Wang J, Abbas Rizvi SM, Madigan MC, Cozzi PJ, Power CA, Qu CF, Morgenstern A, Apostolidis C, Russell PJ, Allen BJ, Li Y. Wang J, et al. Among authors: cozzi pj. Prostate. 2006 Dec 1;66(16):1753-67. doi: 10.1002/pros.20502. Prostate. 2006. PMID: 16955401

6

Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugates.

Li Y, Song E, Abbas Rizvi SM, Power CA, Beretov J, Raja C, Cozzi PJ, Morgenstern A, Apostolidis C, Allen BJ, Russell PJ. Li Y, et al. Among authors: cozzi pj. Clin Cancer Res. 2009 Feb 1;15(3):865-75. doi: 10.1158/1078-0432.CCR-08-1203. Clin Cancer Res. 2009. PMID: 19188157

7

Promising tumor-associated antigens for future prostate cancer therapy.

Li Y, Cozzi PJ, Russell PJ. Li Y, et al. Among authors: cozzi pj. Med Res Rev. 2010 Jan;30(1):67-101. doi: 10.1002/med.20165. Med Res Rev. 2010. PMID: 19536865 Review.

8

Angiogenesis as a strategic target for prostate cancer therapy.

Li Y, Cozzi PJ. Li Y, et al. Among authors: cozzi pj. Med Res Rev. 2010 Jan;30(1):23-66. doi: 10.1002/med.20161. Med Res Rev. 2010. PMID: 19536866 Review.

9

Innovative biomarkers for prostate cancer early diagnosis and progression.

You J, Cozzi P, Walsh B, Willcox M, Kearsley J, Russell P, Li Y. You J, et al. Crit Rev Oncol Hematol. 2010 Jan;73(1):10-22. doi: 10.1016/j.critrevonc.2009.02.007. Crit Rev Oncol Hematol. 2010. PMID: 19328712 Review.

10

MUC1 is a promising therapeutic target for prostate cancer therapy.

Li Y, Cozzi PJ. Li Y, et al. Among authors: cozzi pj. Curr Cancer Drug Targets. 2007 May;7(3):259-71. doi: 10.2174/156800907780618338. Curr Cancer Drug Targets. 2007. PMID: 17504123 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters